VKTX
Viking Therapeutics, Inc.
Stock
$29.94−0.57 (−1.87%)Close Oct 2, 2026
- Net income, 2025
- −$360M
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | −$360M | — |
| 2024 | −$110M | — |
| 2023 | −$86M | — |
| 2022 | −$69M | — |
| 2021 | −$55M | — |
| 2020 | −$39M | — |
| 2019 | −$26M | — |
| 2018 | −$22M | — |
| 2017 | −$21M | — |
| 2016 | −$15M | — |
| 2015 | −$23M | — |
| 2014 | −$22M | — |